Rett, A. Über ein eigenartiges hirnatrophisches Syndrom bei Hyperammonàmie im Kindesalter. Wien Klin Wochenschr
1966; 116: 723–726.
Ishikawa, A, Goto, T, Narasaki, M, et al. A new syndrome (?) of progressive psychomotor deterioration with peculiar stereotype movement and autistic tendency: a report of three cases. Brain Dev (Tokyo)
1978; Old Series No. 3:258 (Abstract in English).
Hagberg, B, Aicardi, J, Dias, K, Ramos, O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol
1983; 14: 471–479.
Hagberg, B, Witt-Engerstròm, I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet
1986; 24: Suppl. 1: 47–59.
Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol
1988; 23: 425–428.
Hagberg, BA, Skjeldal, OH. Rett variants: a suggested model for inclusion criteria. Pediatr Neurol
1994; 11: 5–11.
Zappella, M. The Rett girls with preserved speech. Brain Dev
1992; 14: 98–101.
Haas, RH, Dixon, SD, Sartoris, DJ, Hennessy, MJ. Osteopenia in Rett syndrome. J Pediatr
1997; 131: 771–774.
Leonard, H, Thomson, MR, Glasson, EJ, et al. A population-based approach to the investigation of osteopenia in Rett syndrome. Dev Med Child Neurol
1999; 41: 323–328.
Leonard, H, Thomson, M, Glasson, EJ, et al. Metacarpophalangeal pattern profile and bone age in Rett syndrome: further radiological clues to the diagnosis. Am J Med Genet
1999; 83: 88–95.
Motil, KJ, Schultz, RJ, Browning, K, et al. Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr
1999; 29: 31–37.
Morton, RE, Pinnington, L, Ellis, RE. Air swallowing in Rett syndrome. Dev Med Child Neurol
2000; 42: 271–275.
Hagberg, B. Rett’s syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand
1985; 74: 405–408.
Kerr, AM, Stephenson, JBP. Rett’s syndrome in the West of Scotland. Br Med J
1985; 291: 579–582.
Witt-Engerstròm, I, Gillberg, C. Rett syndrome in Sweden. J Autism Dev Disord
1987; 17: 149–150.
Akesson, HO. Rett syndrome: the Swedish Genealogic Research Project. New data and present position. Eur Child Adolesc Psychiatry
1997; 6 (Suppl 1): 96–98.
Akesson, HO, Hagberg, B, Wahlstrom, J. Rett syndrome, classical and atypical: genealogical support for common origin. J Med Genet
1996; 33: 764–766.
Pini, G, Milan, M, Zappella, M. Rett syndrome in northern Tuscany: family tree studies. Clin Genet
1996; 50: 486–490.
Hollody, K, Borvendeg, K, Kosztolanyi, G. Pedigree analysis of Hungarian Rett syndrome girls. Eur Child Adolesc Psychiatry
1997; 6 (Suppl 1): 99–100.
Leonard, H, Bower, C, English, D. The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 8–10.
Skjeldal, OH, von Tetzchner, S, Aspelung, F, et al. Rett syndrome: geographic variation in prevalence in Norway. Brain Dev
1997; 19: 258–261.
Witt-Engerstròm, I, Forslund, M. Mother and daughter with Rett syndrome. Dev Med Child Neurol
1992; 34: 1022–1023.
Leonard, H, Silverstein, J, Falk, R, et al. Exploring the male phenotype. World Congress on Rett Syndrome
2000, Abstract PO–3, p 34.
Vorsanova, SG, Demidova, IA, Ulas, VY, et al. Cytogenetic and molecular-cytogenetic studies of Rett syndrome (RTT). A retrospective analysis of Russian cohort of RTT patients. World Congress on Rett Syndrome 2000, PO–31:48.
Schanen, NC, Kurczynski, TW, Brunelle, D, et al. Neonatal encephalopathy in two boys in families with recurrent Rett syndrome. J Child Neurol
1998; 13: 229–231.
Wan, M, Lee, SSJ, Zhang, X, et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CPG hotspots. Am J Hum Genet
1999; 65: 1520–1529.
Zoghbi, HY, Percy, AK, Schultz, RJ, Fill, JC. Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev
1990; 12: 131–135.
Ellison, KA, Fill, CP, Terwilliger, J, et al. Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet
1992; 50: 278–287.
Schanen, C, Francke, U. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet
1998; 63: 267–269.
Sirianni, N, Naidu, S, Pereira, J, et al. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet
1998; 63: 1552–1558.
Xiang, F, Zhang, Z, Clarke, A, et al. Chromosome mapping of Rett syndrome: a likely candidate region on the telomere of Xq. J Med Genet
1998; 35: 297–300.
Webb, T, Clarke, A, Hanefeld, F, et al. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28. J Med Genet
1998; 35: 997–1003.
Schanen, NC. Molecular approaches to the Rett syndrome gene. J Child Neurol
1999; 14: 806–814.
Amir, RE, Van den Veyver, IB, Wan, M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet
1999; 23: 185–188.
Willard, HF, Hendrich, BD. Breaking the silence in Rett syndrome. Nature Genet
1999; 23: 127–128.
Hendrich, BD. Methylation moves into medicine. Curr Biol 27 January 2000; 10: R60–R63.
Maraschio, P, Zuffardi, O, Dalla Fior, T, Tiepolo, L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9 and 16, and facial anomalies: the ICF syndrome. J Med Genet
1988; 25: 173–180.
Amir, RE, Van den Veyver, IB, Schultz, R, et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol
2000; 47: 670–679.
Huppke, P, Laccone, F, Kràmer, N, Engel, W, Hanefeld, F. Rett syndrome: analysis of MeCP2 and clinical characterization of 31 patients. Hum Molec Genet
2000; 9: 1369–1375.
Van den Veyver, IB, Zoghbi, HY. Methyl-CpG binding protein 2 mutations in Rett syndrome. Curr Opin Genet Dev
2000; 10: 275–279.
Francke, U. Spectrum of MECP2 mutations in Rett syndrome. World Congress on Rett Syndrome
2000; Symposium S–1;9
Cheadle, JP, Gill, H, Fleming, N, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Molec Genet
2000; 9: 1119–1129.
Nan, X, Guy, J, Hendrich, B, et al. Biological function of the methyl-CPG binding protein MECP2
. World Congress on Rett Syndrome
2000; Abstract KS–II:2.
Christodoulou, J, Weaving, L, Ellaway, C, Leonard, H, Bennetts, B.
MECP2 and Rett Syndrome (RS) – time for a mutation database?
World Congress on Rett Syndrome
Leonard, H, Bower, C. Is the girl with Rett syndrome normal at birth?
Dev Med Child Neurol
1998; 40: 115–121.
Jellinger, K, Armstrong, D, Zoghbi, HY, Percy, AK. Neuropathology of Rett syndrome. Acta Neuropathol
1988; 76: 142–158.
Bauman, ML, Kemper, TL, Arin, DM. Microscopic observations of the brain in Rett syndrome. Neuropediatrics
1995: 26: 105–108.
Oldfors, A, Sourander, P, Armstrong, D, et al. Rett syndrome: cerebellar pathology. Pediatr Neurol
1990; 6: 310–314.
Armstrong, DD. The neuropathology of Rett syndrome: overview 1994. Neuropediatrics
1995; 26: 100–104.
Haas, RH, Love, S. Peripheral nerve findings in Rett syndrome. J Child Neurol
1988: 3 (Suppl): 525–530.
Oldfors, A, Hagberg, B, Nordgren, H, et al. Rett syndrome: spinal cord neuropathy. Pediatr Neurol
1988; 4: 172–174.
Jellinger, K, Grisold, W, Armstrong, D, et al. Peripheral nerve involvement in the Rett syndrome. Brain Dev
1990; 12: 109–114.
Kitt, CA, Wilcox, BJ. Preliminary evidence for neurodegenerative changes in the substantia nigra of Rett syndrome. Neuropediatrics
1995; 26: 114–118.
Belichenko, PV, Hagberg, B, Dahlstròm, A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol
1997; 93: 50–61.
Nomura, Y, Segawa, M. Clinical features of the early stage of the Rett syndrome. Brain Dev
1990; 12: 16–19.
Witt-Engerstròm, I. Age related occurrence of signs and symptoms in the Rett syndrome. Brain Dev
1992; 14: S11–S20.
Naidu, S, Hyman, S, Harris, EL, et al. Rett syndrome studies of natural history and search for a genetic marker. Neuropediatrics
1995; 26: 63–66.
Glaze, DG, Frost, JD, Zoghbi, HY, et al. Rett’s syndrome: correlation of electroencephalographic characteristics with clinical staging. Arch Neurol
1987; 44: 1053–1056.
Robertson, R, Langill, L, Wong, PKH, Ho, HH. Rett syndrome: EEG presentation. Electroencephalogr Clin Neurophysiol
1988; 70: 388–395.
Ho, HH, Wong, PK, Robertson, R. Rett syndrome: clinical profile and EEG abnormalities. Clin Invest Med
1988; 11: 234–241.
Niedermeyer, E, Naidu, S. Further EEG observations in children with the Rett syndrome. Brain Dev
1990; 12: 53–54.
Elian, M, Rudolf, ND. EEG and respiration in Rett syndrome. Acta Neurol Scand
1991; 83: 123–128.
Niedermeyer, E, Naidu, SB, Plate, C. Unusual EEG theta rhythms over central region in Rett syndrome: considerations of the underlying dysfunction. Clin Electroencephalogr
1997; 28: 36–43.
Glaze, DG, Schultz, RJ, Frost, JD. Rett syndrome: characterization of seizures versus nonseizures. Electroencephalogr Clin Neurophysiol
1998; 106: 79–83.
Guerrini, R, Bonanni, P, Parmeggiani, L, et al. Cortical reflex myoclonus in Rett syndrome. Ann Neurol
1998; 43: 472–479.
Yamanouchi, H, Kaga, M, Arima, M. Abnormal cortical excitability in Rett syndrome. Pediatr Neurol
1993; 9: 202–206.
Heinen, F, Petersen, H, Fietzek, U, et al. Transcranial magnetic stimulation in patients with Rett syndrome: preliminary results. Europ Child Adolesc Psychiatry
1997; 6(Suppl 1): 61–63.
Nezu, A, Kimura, S, Takeshita, S, Tanaka, M. Characteristic response to transcranial magnetic stimulation in Rett syndrome. Electroencephalogr Clin Neurophysiol
1998; 109: 100–103.
Badr, GG, Witt-Engerstròm, I, Hagberg, B. Brain stem and spinal cord impairment in Rett syndrome: Somatosensory and auditory evoked responses investigations. Brain Dev
1987; 9: 517–522.
Bader, GG, Witt-Engerstròm, I, Hagberg, B. Neurophysiological findings in the Rett syndrome, I:EMG, conduction velocity, EEG and somatosensory-evoked potential studies. Brain Dev
1989; 11: 102–109.
Nomura, Y, Segawa, M, Hasegawa, M. Rett syndrome – clinical studies and pathophysiological considerations. Brain Dev
1984: 6; 475–486.
Nomura, Y, Segawa, M, Higurashi, M. Rett syndrome – an early catecholamine and indolamine deficient disorder?
1985; 7: 334–341.
Nomura, Y, Segawa, M. Anatomy of Rett syndrome. Am J Med Genet
1986; 24: 289–303.
Segawa, M, Nomura, Y. Pathophysiology of the Rett syndrome from the standpoint of polysomnography. Brain Dev
1990; 12: 55–60.
Segawa, M, Nomura, Y. Polysomnography in the Rett syndrome. Brain Dev
1992; 14 (Suppl) S46–S54.
Felten, DL, Hallman, H, Jonsson, G. Evidence for a neurotrophic role of noradrenaline neurons in the postnatal development of rat cerebral cortex. J Neurocytol
1982; 11: 119–135.
Perry, TL, Dunn, HG, Ho, HH, Crichton, JU. Cerebrospinal fluid values for monoamine metabolites, gamma aminobutyric acid, and other amino compounds in Rett syndrome. J Pediatr
1988; 112: 234–238.
Lekman, A, Witt-Engerstròm, I, Holmberg, B, et al. CSF and urine biogenic amine metabolites in Rett syndrome. Clin Genet
1990; 37: 173–178.
Lekman, A, Witt-Engerstròm, I, Gottfries, J, et al. Rett syndrome: biogenic amines and metabolites in postmortem brain. Pediatr Neurol
1989; 5: 357–362.
Wenk, GL, Naidu, S, Moser, H. Altered neurochemical markers in Rett syndrome. Ann Neurol
1989; 26: 467.
Wenk, GL, Naidu, S, Casanova, MF, et al. Altered neurochemical markers in Rett’s syndrome. Neurology
1991; 41: 1753–1756.
Johnston, MV, Hohmann, C, Blue, M. Neurobiology of Rett syndrome. Neuropediatrics
1995; 26: 119–122.
Berger-Sweeney, J. The effects of neonatal basal forebrain lesions on cognition: towards understanding the developmental role of the cholinergic basal forebrain. Internat J Dev Neurosci
1998; 16: 603–612.
Wenk, GL. Alterations in dopaminergic function in Rett syndrome. Neuropediatrics
1995; 26: 123–125.
Wenk, GL. Rett syndrome: evidence for normal dopaminergic function. ibid. 1996; 27: 256–259.
Kaufmann, WE, Taylor, CV, Hohmann, CF, et al. Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 75–77.
Naidu, S. Rett syndrome: a disorder affecting early brain growth. Ann Neurol
1997; 42: 3–10.
Li, Y, Holtzman, DM, Kromer, LF, et al. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci
1995; 15: 2888–2905.
Lin, LF, Doherty, DH, Lile, JD, et al. GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science
1993; 260: 1130–1132.
Lappalainen, R, Lindholm, D, Riikonen, R. Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol
1996; 11: 296–300.
Vanhala, R, Korkonen, L, Mikelsaar, M, et al. Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome. J Child Neurol
1998; 13: 429–433.
Riikonen, R, Vanhala, R. Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome. Dev Med Child Neurol
1999; 41: 148–152.
Wenk, GL, Hauss-Wegrzynriak, B. Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics
1999; 30: 125–129.
Hohmann, CF, Berger-Sweeney, J. Cholinergic regulation of cortical development and plasticity. New twists to an old story. Perspect Dev Neurobiol
1998; 5: 401–425.
Nomura, Y, Kimura, K, Arai, H, Segawa, M. Involvement of the autonomic nervous system in the pathophysiology of Rett syndrome. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 42–46.
Julu, PO, Kerr, AM, Hansen, S, et al. Functional evidence of brain stem immaturity in Rett syndrome. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 47–54.
Sekul, EA, Moak, JP, Schultz, RJ, et al. Electrocardiographic findings in Rett syndrome: explanation for sudden death?
1994; 125: 80–82.
Dearlove, OR, Walker, RWM: Case Reports: Anaesthesia for Rett Syndrome. Paediatr Anaesth
1996; 6: 155–158.
Ellaway, CJ, Sholler, G, Leonard, H, Christodoulou, J. Prolonged QT interval in Rett syndrome. Arch Dis Child
1999; 80: 470–472.
Guideri, F, Acampa, M, Hayek, G, et al. Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death. Neuropediatrics
1999; 30: 146–148.
Witt-Engerstròm, I, Kerr, A, eds. Workshop on autonomic function in Rett syndrome. Swedish Rett Center, Fròsòn, Sweden, May 1998. Brain Dev
1998; 20: 323–326.
Lju ngberg, A-W, Hagberg, B. Rett syndrome, one-sided sympathectomy. Unilateral foot normalization. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 55.
Armstrong, DD, Panigrahy, A, Sleeper, LA, Kinney, HC. Preliminary studies demonstrating increased [3H] lysergic acid diethylamide ([3H] LSD) binding to serotonin receptors in selected nuclei of the brain stem in Rett syndrome. Brain Dev
1998; 20: 323–326.
Jessell, TM, Emson, PC, Paxinos, G, Cuello, AC. Topographic projections of Substance P and GABA pathways in the striato-and pallido-nigral system: a biochemical and immunohisto-chemical study. Brain Res
1978; 152: 487–498.
Nikolaus, S, Huston, JP, Hasenohrl, RU. Reinforcing effects of neurokinin Substance Pin the ventral pallidum: mediation by the tachykinin NKI receptor. Eur J Pharmacol
1999; 370: 93–99.
Kramer, MS, Cutler, N, Feighner, J, et al. Distinct mechanism for antidepressant activity by blockade of central Substance P receptors. Science
1998; 281: 1640–1645.
Nicoll, RA, Schenker, C, Leeman, SE. Substance P as a transmitter candidate. Ann Rev Neurosci
1980; 3: 227–268.
Rimon, R, Greves, PL, Nyberg, F, et al. Elevation of Substance P-like peptides in the CSF of psychiatric patients. Biol Psychiatry
1984; 19: 509–516.
Russell, IJ, Orr, MD, Littman, B, et al. Elevated cerebrospinal fluid levels of Substance Pin patients with the fibromyalgia syndrome. Arthritis Rheum
1994; 37: 1593–1601.
Matsuishi, T, Nagamitsu, S, Yamashita, Y, et al. Decreased cerebrospinal fluid levels of Substance P in patients with Rett syndrome. Ann Neurol
1997; 42: 978–981.
Deguchi, K, Antalffy, BA, Twohill, LJ, et al. Substance P immunoreactivity in Rett syndrome. Pediatr Neurol
2000; 22: 259–266.
Matsuishi, T, Urabe, F, Percy, AK, et al. Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome. J Child Neurol
1994; 9: 26–30.
Haas, RH, Nasirian, F, Hua, X, et al. Oxidative metabolism in Rett syndrome: 2. Biochemical and molecular studies. Neuropediatrics
1995; 26: 95–99.
Budden, SS, Myer, EC, Butler, IJ. Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta endorphins. Brain Dev
1990; 12: 81–84.
Echenne, B, Bressot, N, Bassir, M, et al. Cerebrospinal fluid β-endorphin and cortisol study in Rett syndrome. J Child Neurol
1991; 6: 257–262.
Nielsen, JB, Bach, FW, Buchholt, J, Lou, H. Cerebrospinal fluid β-endorphin in Rett syndrome. Dev Med Child Neurol
1991; 33: 406–411.
Myer, EC, Tripathi, HL, Brase, DA, Dewey, WL. Elevated CSF β-endorphin immunoreactivity in Rett’s syndrome: report of 158 cases and comparison with leukemic children. Neurology
1992; 42: 357–360.
Percy, AK, Glaze, DG, Schultz, RJ, et al. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol
1994; 35: 464–470.
Lekman, AY, Hagberg, BA, Svennerholm, LT. Membrane cerebral lipids in Rett syndrome. Pediatr Neurol
1991; 7: 186–190.
Lekman, AY, Hagberg, BA, Svennerholm, LT. Cerebrospinal fluid gangliosides in patients with Rett syndrome and infantile neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol
1999; 3: 119–123.
Hamberger, A, Gillberg, C, Palm, A, Hagberg, B. Elevated CSF glutamate in Rett syndrome. Neuropediatrics
1992; 23: 212–213.
Lappalainen, R, Riikonen, RS. High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatr Neurol
1996; 15: 213–216.
Uldall, P, Hansen, FJ, Tonnby, B. Lamotrigine in Rett syndrome. Neuropediatrics
1993; 24: 339–340.
Stenbom, Y, Tonnby, B, Hagberg, G. Lamotrigine in Rett syndrome: treatment experience from a pilot study. Eur Child Adolesc Psychiatry
1998; 7: 49–52.
Giordano, L, Capovilla, G, Beccaria, F, et al. LTG therapy in 5 patients with Rett syndrome and epilepsy with the onset in the first 24 months of age. Bollettino-Lega Italiana Contra L’Epilessia
1998; 102–103: 151–152.
McDonald, JW, Johnston, MV. Physiological and patho-physiological roles of excitatory amino acids during central nervous system development. Brain Res Rev
1990; 15: 41–70.
Blue, ME, Naidu, S, Johnston, MV. Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol
1999; 45: 541–545.
Langlais, PJ, Walsh, FX, Bird, ED, Levy, HL. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children. Pediatrics
1985; 75: 580–586.
Blue, ME, Naidu, S, Johnston, MV. Altered development of glutamate and GABAreceptors in the basal ganglia of girls with Rett syndrome. Exp Neurol
1999; 156: 345–352.
Satoi, M, Matsuishi, T, Yamada, S, et al. Decreased cerebrospinal fluid levels of β-phenylethylamine in patients with Rett syndrome. Ann Neurol
2000; 47: 801–803.
Casanova, MF, Naidu, S, Goldberg, T, et al. Quantitative magnetic resonance imaging in Rett syndrome. J Neuropsychiatry
1991; 3: 366–372.
Murakami, JW, Courchesne, E, Haas, RH, et al. Cerebellar and cerebral abnormalities in Rett syndrome: a quantitative MR analysis. AJR Am J Roentgenol
1992; 159: 177–183.
Reiss, AL, Faruque, F, Naidu, S, et al. Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol
1993; 34: 227–234.
Subramaniam, B, Naidu, S, Reiss, AL. Neuroanatomy in Rett syndrome: cerebral cortex and posterior fossa. Neurology
1997; 48: 399–407.
Nielsen, JB, Toft, PB, Reske-Nielsen, E, et al. Cerebral magnetic resonance spectroscopy in Rett syndrome. Failure to detect mitochondrial disorder. Brain Dev
1993; 15: 107–112.
Hanefeld, F, Christen, HJ, Holzbach, U, et al. Cerebral proton magnetic resonance spectroscopy in Rett syndrome. Neuropediatrics
1995; 26: 126–127.
Hashimoto, T, Kawano, N, Fukuda, K, et al. Proton magnetic resonance spectroscopy of the brain in 3 cases of Rett syndrome: comparison with autism and normal controls. Acta Neurol Scand
1998; 98: 8–14.
Pan, JW, Lane, JB, Hetherington, H, Percy, AK. Rett syndrome: 1H spectroscopic imaging at 4.1 Tesla. J Child Neurol
Horská, A, Naidu, S, Herskovits, EH, et al. Quantitative 1H MR spectroscopic imaging in early Rett syndrome. Neurology
2000; 54: 715–722.
Nielsen, JB, Friberg, L, Lou, H, et al. Immature pattern of brain activity in Rett syndrome. Arch Neurol
1990; 47: 982–986.
Lappalainen, R, Liewendahl, K, Sainio, K, et al. Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Neurol Scand
1997; 95: 44–50.
Bjure, J, Uvebrant, P, Vestergren, E, Hagberg, B. Regional cerebral blood flow abnormalities in Rett syndrome. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 64–66.
Burroni, L, Aucone, AM, Volterrani, D, et al. Brain perfusion abnormalities in Rett syndrome: a qualitative and quantitative SPECT study with 99Tc(m)-ECD. Nucl Med Commun
1997; 18: 527–534.
Yoshikawa, H, Fueki, N, Suzuki, H, et al. Cerebral blood flow and oxygen metabolism in Rett syndrome. J Child Neurol
Harris, JC, Wong, DF, Wagner, HN, et al. Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome. Am J Med Genet
1986; 24(Suppl 1): 201–210.
Snow, BJ, Tooyama, I, McGeer, EG, et al. Human positron emission tomographic [18F] fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol
1993; 34: 324–330.
Pate, BD, Kawamata, T, Yamada, T, et al. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices. Ann Neurol
1993; 34: 331–338.
Trebossen, R, Bendriem, B, Ribeiro, MJ, et al. Validation of the three-dimensional acquisition mode in Positron Emission Tomography for quantitation of [18F] fluoro-Dopa uptake in human striata. J Cereb Blood Flow Metab
1998; 18: 951–959.
Pietrzyk, U, Herholz, K, Fink, G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CTbrain studies. J Nucl Med
1994; 35: 2011–2018.
Wong, DF, Ricaurte, G, Gründer, G, et al. Dopamine transporter changes in neuropsychiatric disorders. Adv Pharmacol
1998, 42: 219–223.
Chiron, C, Bultreau, C, Loch, C, et al. Dopaminergic D2 receptor SPECTimaging in Rett syndrome: increase of specific binding in striatum. J Nucl Med
1993; 34: 1717–1721.
Naidu, S, Kaufmann, W, Abrams, M, et al. Neuroimaging studies in Rett syndrome. World Congress on Rett Syndrome 2000. Plenary Lecture-IV:6.
Cordes, M, Snow, BJ, Cooper, S, et al. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Ann Neurol
1994; 36: 667–670.
Nomura, Y. Neurophysiology of Rett syndrome. World Congress on Rett Syndrome 2000. Plenary Lecture-II: 4.
Filipek, PA, Accardo, PJ, Ashwal, S, et al. Screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology
2000; 55: 468–479.
Chiron, C, Leboyer, M, Leon, F, et al. SPECT of the brain in childhood autism: evidence for a lack of normal hemispheric asymmetry. Dev Med Child Neurol
1995; 37: 849–860.
Chugani, DC, Muzik, O, Behen, M, et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol
1999; 45: 287–295.
Ellaway, C, Buchholz, T, Smith, A, Leonard, H, Christodoulou, J. Rett syndrome: significant clinical overlap with Angelman syndrome but not with methylation status. J Child Neurol
1998; 13: 448–451.
Budden, SS. Management of Rett syndrome: a ten-year experience. Neuropediatrics
1995; 26: 75–77.
Budden, SS. Rett syndrome: habilitation and management reviewed. Eur Child Adolesc Psychiatry
1997; 6(Suppl 1): 103–107.